| Literature DB >> 6307706 |
R M Bukowski, L P Leichman, S E Rivkin.
Abstract
Twenty-three patients with gallbladder and cholangiocarcinoma were treated with m-AMSA at doses of 60-120 mg/m2 i.v. repeated at 4-week intervals. Toxicity was primarily hematologic. Partial responses occurred in 1/12 patients with gallbladder cancer and 1/11 patients with cholangiocarcinoma. The activity of m-AMSA in these neoplasms appears similar to that seen in hepatomas.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6307706 DOI： 10.1016/0277-5379(83)90004-4
Source DB: PubMed Journal: Eur J Cancer Clin Oncol ISSN： 0277-5379